Dowdy Jackson

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

Dana M. Brantley, Nikki Cheng, Erin J Thompson et al. · Oncogene · 2002 · 316 citations

Angiogenesis, Medicine, Immunology +6

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

Dana M. Brantley‐Sieders, Guanglei Zhuang, Donna J. Hicks et al. · Journal of Clinical Investigation · 2008 · 276 citations · Full text

Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles

Stasia A. Anderson, Randall K. Rader, William Westlin et al. · Magnetic Resonance in Medicine · 2000 · 273 citations · Full text

Nanoparticles, Nanomedicine, Targeted Contrast Agent +15

Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy

Guanglei Zhuang, Dana M. Brantley‐Sieders, David Vaught et al. · Cancer Research · 2009 · 206 citations · Full text

Trastuzumab Resistance, Breast Oncology, Signal Transduction +11

Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation <i>in vitro</i> and <i>in vivo</i>

Ta-Jen Liu, Tiffany A. LaFortune, Toshiyuki Honda et al. · Molecular Cancer Therapeutics · 2007 · 203 citations